Jorge Urzua

Renal function and cardiopulmonary bypass : effect of perfusion pressure

Controversy continues as to whether hypotension during cardiopulmonary bypass (CPB) impairs intraoperative and postoperative renal function. Therefore, 21 patients with normal renal function (plasma creatinine less than 1.2 mg/dL, creatinine clearance greater than 70 mL/min), aged 50 to 70 years, without associated pathology, scheduled for elective coronary surgery were studied prospectively. Patients were randomized into two groups: group 1 included 14 patients whose arterial blood pressure during CPB was left untreated, and group 2 consisted of 7 patients who received phenylephrine to maintain their arterial pressure above 70 mmHg. Plasma and urine creatinine, sodium, potassium, and osmolality were measured preoperatively, intraoperatively and postoperatively. Creatinine, osmolal and free water clearances, and excreted sodium fraction were calculated. Plasma creatinine remained normal throughout the study in all patients. Creatinine clearances were similar preoperatively (101.9 +/- 36.7 in group 1 and 120.6 +/- 50.7 mL/min in group 2). In group 1, creatinine clearance decreased during CPB to 88.7 +/- 39.7 mL/min, whereas in group 2 it increased to 157.6 +/- 79.5 mL/min; the difference between groups was significant. Early postoperatively, there was no difference: 136.2 +/- 86.6 mL/min in group 1 and 100 +/- 21.4 mL/min in group 2. One week postoperatively, values were 100.5 +/- 37.9 and 101.9 +/- 18.4, respectively. There was a significant correlation between the creatinine clearance and perfusion pressure intraoperatively, but not postoperatively. Osmolal clearance also correlated with perfusion pressure intraoperatively, but it was significantly lower in the phenylephrine group postoperatively. Postoperative renal function was normal in all patients; no deleterious effect of a low arterial pressure during bypass could be identified.

Anesthesia for Elective Cardioversion: A Comparison of Four Anesthetic Agents

Elective cardioversion is a short procedure performed under general anesthesia for the treatment of cardiac dysrhythmias. Selection of the anesthetic agent is important, because a short duration of action and hemodynamic stability are required. Forty-four patients scheduled for elective cardioversion in the coronary care unit were studied prospectively. All patients were randomly assigned, according to the last digit of their clinical record number, to receive one of the four anesthetic agents studied: group 1, 12 patients who received 3 mg/kg of sodium thiopental; group 2, 10 patients who received 0.15 mg/kg of etomidate; group 3, 12 patients who received 1.5 mg/kg of propofol; and group 4, 10 patients who received 0.15 mg/kg of midazolam. All patients also received 1.5 micrograms/kg of fentanyl 3 minutes before induction. All four drugs provided satisfactory anesthesia for cardioversion and there were no major complications. Midazolam produced a more prolonged duration of effect and more interindividual variability. Propofol was associated with hypotension and a higher incidence of apnea, and its duration of action was similar to that of etomidate or thiopental. Etomidate produced myoclonus and pain on injection; however, it was the only agent that did not decrease arterial blood pressure. Thiopental reduced blood pressure but otherwise seemed an appropriate anesthetic for this procedure. In conclusion, all four anesthetic agents were acceptable for cardioversion, although their pharmacological differences suggest specific indications for individual patients.

Effects of extracorporeal circulation on renal function in coronary surgical patients

We prospectively studied perioperative changes of renal function in 12 previously normal patients (plasma creatinine <1.5 mg/dL) scheduled for elective coronary surgery. Glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) were measured with inulin and125 I-hippuran clearances before induction of anesthesia, before cardiopulmonary bypass (CPB), during hypo- and normothermic CPB, after sternal closure, and 1 h postoperatively. Renal and systemic vascular resistances were calculated. Urinary N-acetyl-beta-D-glucosaminidase (NAG) and plasma and urine electrolytes were measured, and free water, osmolal, and creatinine clearances, and fractional excretion of sodium and potassium were calculated before and after surgery.125 I-hippuran clearance was lower than normal in all patients before surgery. During hypothermic CPB, ERPF increased significantly (from 261 +/- 107 to 413 +/- 261 mL/min) and returned toward baseline values during normothermia. GFR was normal before and after surgery and decreased nonsignificantly during CPB. Filtration fraction was above normal before surgery and decreased significantly during CPB (0.38 +/- 0.09 to 0.18 +/- 0.06). Renal vascular resistance (RVR) was high before surgery and further increased after sternotomy (from 18,086 +/- 6849 to 30,070 +/- 24,427 dynes centered dot s centered dot cm-5), decreasing during CPB to 13,9647 +/- 14,662 dynes centered dot s centered dot cm-5. Urine NAG, creatinine, and free water clearances were normal in all patients both pre- and postoperatively. Osmolal clearance and fractional excretion of sodium increased postoperatively from 1.54 +/- 0.06 to 12.47 +/- 11.37 mL/min, and from 0.44 +/- 0.3 to 6.07 +/- 6.27, respectively. We conclude that renal function does not seem to be adversely affected by CPB. Significant functional alterations, such as decreased ERPF and increased RVR, were found before and during surgery, preceding CPB. These periods could contribute to postoperative renal dysfunction. (Anesth Analg 1995;81:446-51)

Renal protection in patients undergoing cardiopulmonary bypass with preoperative abnormal renal function

We prospectively studied the effects of renal protection intervention in 17 patients with preoperative abnormal renal function (plasma creatinine >1.5 mg/dL) scheduled for elective coronary surgery. Patients were randomized to either dopamine 2.0 micro g [center dot] kg-1 [center dot] min-1 (Group 1

An Expert System for Monitor Alarm Integration

Objective. Intensive care and operating room monitors generate data that are not fully utilized. False alarms are so frequent that attending personnel tends to disconnect them. We developed an expert system that could select and validate alarms by integration of seven vital signs monitored on-line from cardiac surgical patients. Methods. The system uses fuzzy logic and is able to work under incomplete or noisy information conditions. Patient status is inferred every 2 seconds from the analysis and integration of the variables and a unified alarm message is displayed on the screen. The proposed structure was implemented on a personal computer for simultaneous automatic surveillance of up to 9 patients. The system was compared with standard monitors (SpaceLabsTM PC2), using their default alarm settings. Twenty patients undergoing cardiac surgery were studied, while we ran our system and the standard monitor simultaneously. The number of alarms triggered by each system and their accuracy and relevance were compared. Two expert observers (one physician, one engineer) ascertained each alarm reported by each system as true or false. Results. Seventy-five percent of the alarms reported by the standard monitors were false, while less than 1% of those reported by the expert system were false. Sensitivity of the standard monitors was 79% and sensitivity of the expert system was 92%. Positive predictive value was 31% for the standard monitors and 97% for the expert system. Conclusions. Integration of information from several sources improved the reliability of alarms and markedly decreased the frequency of false alarms. Fuzzy logic may become a powerful tool for integration of physiological data.

Comparison of Hemodynamic and Hormonal Effects of Large Single-dose Fentanyl Anesthesia and Halothane/nitrous Oxide Anesthesia for Coronary Artery Surgery

This study was conducted to compare our standard halothane/N2O anesthetic technique with large single-dose fentanyl (150 μg/kg)/O2 anesthesia in patients undergoing coronary artery surgery. We chose to look at two discrete stimuli (tracheal intubation and sternotomy) and measured changes in mean arterial pressure, heart rate, mean pulmonary artery occluded pressure, PAO cardiac output, derived indices (stroke volume, rate-pressure product, systemic vascular resistance, and changes in the plasma concentrations of growth hormone, epinephrine, norepi-nephrine, and renin activity. Both groups of patients were comparable in age, height, weight, and surface area. Variance in hemodynamic functions did not reach undesirable levels in either group. In the patients given fentanyl, there was a significant increase in heart rate after pancuronium administration. Mean arterial pressure and mean pulmonary artery occluded pressure did not change significantly from control values in either group; however, there was enough divergence between groups for the changes to be statistically significant. Cardiac output decreased in both groups after sternotomy. There was no significant change in systemic vascular resistance in either group. The only significant hormonal change was a significant increase in plasma levels of growth hormone in patients who received halothane/N2O for anesthesia (p < 0.001). Plasma fentanyl concentrations decreased rapidly after bolus administration consistent with pharmacokinetics previously described. Of the 10 patients given fentanyl two were aware during sternotomy; of the 12 patients in the halothane group none had awareness. We believe that large-dose fentanyl offered better preservation of coronary perfusion and more attenuation of the hormonal flux observed with stress than halothane/N2O anesthesia. Large-dose fentanyl may offer more advantages in patients with greater ventricular impairment.

Renal function and cardiopulmonary bypass in pediatric cardiac surgical patients.

We studied prospectively the perioperative changes of renal function in nine children undergoing cardiac surgery with cardiopulmonary bypass (CPB). Glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) were measured with inulin and 131I-hippuran clearances before CPB, during hypo and normothermic CPB, following sternal closure and 1 h postoperatively. Urinary alpha glutathione S-transferase (alpha GS-T) was measured pre- and postoperatively as a marker for tubular cellular damage. Plasma and urine creatinine and electrolytes were measured. Free water, osmolal and creatinine clearances, as well as fractional excretion of sodium (FeNa) and potassium transtubular gradient (TTKG) were calculated. GFR was normal before and after surgery. ERPF was low before and after surgery; it increased significantly immediately after CPB. Filtration fraction (FF) was abnormally elevated before and after surgery; however, a significant decrease during normothermic CPB and sternal closure was found. Alpha GS-T presented a moderate, but nonsignificant increase postoperatively. FeNa also increased in this period, but not significantly. Creatinine, osmolal, free water clearances, as well as TTKG, were normal in all patients pre- and postoperatively. We conclude that there is no evidence of clinically significant deterioration of renal function in children undergoing repair of cardiac lesions under CPB. Minor increases of alpha GS-T in urine postoperatively did not confirm cellular tubular damage. There was no tubular dysfunction at that time.

Arterial pressure-flow relationship in patients undergoing cardiopulmonary bypass.

We determined the arterial pressure-flow relationship experimentally by means of step changes of blood flow in 30 adult patients undergoing cardiopulmonary bypass (CPB). Anesthesia technique was uniform. CPB was nonpulsatile; hypothermia to 25-28 degrees C, and hemodilution to 18%-25% hematocrit were used. During stable bypass, mean arterial pressure was recorded first with blood flow 2.2 L [centered dot] min (-1) [centered dot] m-2. Flow was then increased to 2.9 L [centered dot] min (-1) [centered dot] m-2 for 10 s and reverted to baseline for 1 min. Then it was decreased to 1.45 L [centered dot] min-1 [centered dot] m-2 for 10 s, and reverted to baseline for 1 min. Subsequently, it was decreased to 0.73 L [centered dot] min-1 [centered dot] m-2 for 10 s and then reverted to baseline. Similar sets of measurements were repeated after 0.25 mg of phenylephrine and once the patient was rewarmed. The pressure-flow function was individually determined by regression, and the critical pressure estimated by extrapolation to zero flow. All patients had zero-flow critical pressure during hypothermia, with a mean value of 21.8 +/- 6.4 mm Hg (range 8.8-38.9). It increased after 0.25 mg phenylephrine to 25.4 +/- 7.2 mm Hg (range 12.2-43.9, P < 0.001). During normothermia, critical pressure was 21.2 +/- 5 mm Hg (range 13.4-30.9), not significantly different from hypothermia. During hypothermia, the slope of the pressure-flow function (i.e., resistance) was 14.9 +/- 3.5 mm Hg [centered dot] L-1 [centered dot] min-1 [centered dot] m-2 (range 7.6-22.1). It increased significantly (P < 0.001) after phenylephrine, to 19.7 +/- 6.2 mm Hg [centered dot] L-1 [centered dot] min-1 [centered dot] m-2 (range 11.4-40.5), and returned to 15.4 +/- 3.4 mm Hg [centered dot] L-1 [centered dot] min-1 [centered dot] m-2 (range 10.1-24.2) during normothermic bypass. Systemic vascular resistance appeared to vary reciprocally with blood flow, although this finding may represent a mathematical artifact, which can be avoided by using zero-flow critical pressure in the vascular resistance equation. (Anesth Analg 1997;84:958-63)

Successful anesthetic management of a patient with hypokalemic familial periodic paralysis undergoing cardiac surgery.

Hypokalemic familial periodic paralysis is a rare disease, with obvious anesthetic implications. We report a case of a patient with known hypokalemic familial periodic paralysis, who required coronary revascularization. An impending episode of paralysis on the Ist postoperative day was aborted by aggressive management of plasma potassium concentration

Renal preservation in cardiac surgery.

There is no conclusive evidence that any pharmacological intervention is able to offer effective protection for the kidneys during cardiac surgery. More research is needed into the underlying mechanisms of postoperative renal failure, specifically with regard to the possible role played by endothelial factors and inflammatory response.